INOVIO to participate in Piper Sandler, Oppenheimer healthcare conferences.

INOVIO, a biotechnology company, will participate in the Piper Sandler 37th Annual Healthcare Conference and the Oppenheimer Movers in Rare Disease Summit. The company's management team will conduct one-on-one meetings with investors and participate in a fireside chat and panel discussion. INOVIO is focused on developing DNA medicines for HPV-associated diseases, cancer, and infectious diseases.